These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26156418)

  • 21. Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel.
    Abouelmagd SA; Ku YJ; Yeo Y
    J Drug Target; 2015; 23(7-8):725-35. PubMed ID: 26453168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
    Guo F; Zhang M; Gao Y; Zhu S; Chen S; Liu W; Zhong H; Liu J
    Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasal adaptive chitosan-based nano-vehicles for anti-allergic drug delivery.
    Sun M; Yu X; Wang T; Bi S; Liu Y; Chen X
    Int J Biol Macromol; 2019 Aug; 135():1182-1192. PubMed ID: 31154036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery.
    Rejinold NS; Sreerekha PR; Chennazhi KP; Nair SV; Jayakumar R
    Int J Biol Macromol; 2011 Aug; 49(2):161-72. PubMed ID: 21536066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Developments in the Area of Click-Crosslinked Nanocarriers for Drug Delivery.
    Dai Y; Chen X; Zhang X
    Macromol Rapid Commun; 2019 Feb; 40(3):e1800541. PubMed ID: 30417477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multilayer sodium alginate beads with porous core containing chitosan based nanoparticles for oral delivery of anticancer drug.
    Li J; Jiang C; Lang X; Kong M; Cheng X; Liu Y; Feng C; Chen X
    Int J Biol Macromol; 2016 Apr; 85():1-8. PubMed ID: 26724684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-linked chitosan in nano and bead scales as drug carriers for betamethasone and tetracycline.
    Taghizadeh MT; Ashassi-Sorkhabi H; Afkari R; Kazempour A
    Int J Biol Macromol; 2019 Jun; 131():581-588. PubMed ID: 30885730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multivalency in Drug Delivery-When Is It Too Much of a Good Thing?
    Tjandra KC; Thordarson P
    Bioconjug Chem; 2019 Mar; 30(3):503-514. PubMed ID: 30742420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan nanoparticles for oral drug and gene delivery.
    Bowman K; Leong KW
    Int J Nanomedicine; 2006; 1(2):117-28. PubMed ID: 17722528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De-esterified tragacanth-chitosan nano-hydrogel for methotrexate delivery; optimization of the formulation by Taguchi design.
    Sadrjavadi K; Shahbazi B; Fattahi A
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):883-893. PubMed ID: 29764208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical development and regulatory considerations for nanoparticles and nanoparticulate drug delivery systems.
    Narang AS; Chang RK; Hussain MA
    J Pharm Sci; 2013 Nov; 102(11):3867-82. PubMed ID: 24037829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier.
    Pontillo ARN; Detsi A
    Nanomedicine (Lond); 2019 Jul; 14(14):1889-1909. PubMed ID: 31274373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil.
    Mohammed M; Mansell H; Shoker A; Wasan KM; Wasan EK
    Drug Dev Ind Pharm; 2019 Jan; 45(1):76-87. PubMed ID: 30169982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitosan mediated targeted drug delivery system: a review.
    Patel MP; Patel RR; Patel JK
    J Pharm Pharm Sci; 2010; 13(4):536-57. PubMed ID: 21486530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel nanoparticles based on chitosan-dicarboxylate conjugates via tandem ionotropic/covalent crosslinking with tripolyphosphate and subsequent evaluation as drug delivery vehicles.
    Dmour I; Taha MO
    Int J Pharm; 2017 Aug; 529(1-2):15-31. PubMed ID: 28634140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal nanoparticle design for effective transport through the blood-brain barrier.
    Park K
    J Control Release; 2019 Feb; 295():290. PubMed ID: 30704674
    [No Abstract]   [Full Text] [Related]  

  • 37. Zein nanoparticles as vehicles for oral delivery purposes.
    Irache JM; González-Navarro CJ
    Nanomedicine (Lond); 2017 Jun; 12(11):1209-1211. PubMed ID: 28520512
    [No Abstract]   [Full Text] [Related]  

  • 38. Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery.
    Ahmed TA; Aljaeid BM
    Drug Des Devel Ther; 2016; 10():483-507. PubMed ID: 26869768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and Characterization of Mucoadhesive Buccal Nanoparticles Using Chitosan and Dextran Sulfate.
    Suh JW; Lee JS; Ko S; Lee HG
    J Agric Food Chem; 2016 Jul; 64(26):5384-8. PubMed ID: 27222213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A self-targeting and controllable drug delivery system constituting mesoporous silica nanoparticles fabricated with a multi-stimuli responsive chitosan-based thin film layer.
    Chen C; Yao W; Sun W; Guo T; Lv H; Wang X; Ying H; Wang Y; Wang P
    Int J Biol Macromol; 2019 Feb; 122():1090-1099. PubMed ID: 30219514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.